2024 Pharmacokinetics Protein Expression 
Alta Sciences
APRIL 17, 2024
Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.
Drug Target Review
JANUARY 20, 2025
Molecular factors Molecular markers, such as protein expression and signalling pathway activation, also guide therapy choices. For example, PD-L1 expression predicts the response to immune checkpoint inhibitors. This approach underlies the identification of the OBD, backed by both clinical efficacy and drug tolerability data.
Expert insights. Personalized for you.
52 
Let's personalize your content